[Effects of rifampicin on the menstrual cycle and on oestrogen excretion in patients taking oral contraceptives].
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004964:Estriol / Q000652:urine; D004967:Estrogens / Q000652:urine*; D004970:Estrone / Q000652:urine; D004977:Ethambutol / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000139:chemically induced*; D011247:Pregnancy; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D003276:Contraceptives, Oral; D004967:Estrogens; D004970:Estrone; D004997:Ethinyl Estradiol; D004977:Ethambutol; D004964:Estriol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Wirkung von Rifampicin auf den Menstruationszyklus und die Ostrogenausscheidung bei Einnahme oraler Kontrazeptiva.